Two types of environmental antiseptic wipes, A and B, were manufactured using nonwoven fabrics. We evaluated the growth-inhibitory effects of the wipes on bacterial strains such as extended-spectrum β–lactamase (ESBL) (CTX M–1 type)
Escherichia coli, carbapenem and quinolone resistant
Pseudomonas aeruginosa (two-drug-resistant
P. aeruginosa),
Acinetobacter baumanii (
A. baumanii), MRSA, and vancomycin-resistant enterococcii (VRE) (
vanB type) under various conditions. The residual performance of the wipes was examined by wiping once on surfaces contaminated with bacteria. The residual level of the antiseptic agent of wipe A was within the detection limit. The growth of ESBL–producing
E. coli,
A. baumanii and MRSA was inhibited by not less than 99.99% 4 h after wiping, and that of the other 2 bacterial strains was slightly inhibited from 4+ to 2+ or 1+ by the use of wipe B, indicating retention of the antiseptic agent. In the case of a bacterial fluid prepared from skimmed milk, wipe A showed slight growth inhibitory effect on all bacterial strains, whereas wipe B exhibited strong growth inhibitory effect on two-drug-resistant strain P.aeruginosa and VRE by not less than 99.99%, along with slight growth inhibitory effect on the other 2 bacterial strains. The reduction in bacterial count was determined by wiping once the right side (with wipe A) and the left side (with wipe B) of a toilet seat, and comparing the final bacterial count, considering the count of bacteria adhering to the surface of the toilet seat before wiping as control. Wipe B showed a statistically significant difference with respect to reduction in bacterial count compared to wipe A. We attribute the observed results to the fact that wipe B contains a 10–times higher quantity of benzalkonium chloride than wipe A and surfactant. Moreover, the use of an increased amount of nonwoven fabric for constructing wipe B contributed to the effectiveness for the control of nosocomial infections.
View full abstract